ClinicalTrials.Veeva

Menu

Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study (PREFER-PP)

M

Marc Blondon

Status

Completed

Conditions

Venous Thromboembolism
Pregnancy Related

Treatments

Other: Interview

Study type

Observational

Funder types

Other

Identifiers

NCT05897697
UGeneva 2021-01336

Details and patient eligibility

About

The preferences of pregnant women for postpartum thromboprophylaxis are largely unknown. The aims of this transversal study are to elicit the preferences of pregnant/postpartum women about postpartum thromboprophylaxis in semi-structured interviews, and to estimate the utility of the relevant health states (pulmonary embolism, deep vein thrombosis, postpartum hemorrhage, subcutaneous injections). In this second aim, the investigators will also compare the effect of 2 different techniques to estimate utilities (standard gamble vs. time trade-off), using a randomization of these techniques.

Enrollment

122 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • women
  • ongoing pregnancy or within 7 days of delivery
  • fluency in French or English

Exclusion criteria

  • fetal or neonatal death

Trial design

122 participants in 1 patient group

Pregnant / postpartum women
Description:
Adult women during pregnancy or the early postpartum period (within 7 days of delivery)
Treatment:
Other: Interview

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems